HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Debra Donaldson Selected Research

plozalizumab

3/2011Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Debra Donaldson Research Topics

Disease

1Cardiovascular Diseases (Cardiovascular Disease)
03/2011
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2011
1Inflammation (Inflammations)
03/2011
1Atherosclerotic Plaque (Atheroma)
03/2011

Drug/Important Bio-Agent (IBA)

1plozalizumabIBA
03/2011
1C-Reactive ProteinIBA
03/2011
1LigandsIBA
03/2011
1Biomarkers (Surrogate Marker)IBA
03/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2011
1CC ChemokinesIBA
03/2011
1CCR2 ReceptorsIBA
03/2011